Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AZITHROMYCIN Cause Central nervous system lesion? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Central nervous system lesion have been filed in association with AZITHROMYCIN (AZITHROMYCIN). This represents 0.0% of all adverse event reports for AZITHROMYCIN.

5
Reports of Central nervous system lesion with AZITHROMYCIN
0.0%
of all AZITHROMYCIN reports
1
Deaths
5
Hospitalizations

How Dangerous Is Central nervous system lesion From AZITHROMYCIN?

Of the 5 reports, 1 (20.0%) resulted in death, 5 (100.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.

Is Central nervous system lesion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AZITHROMYCIN. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does AZITHROMYCIN Cause?

Off label use (2,979) Drug ineffective (2,609) Drug hypersensitivity (1,978) Dyspnoea (1,409) Condition aggravated (1,063) Nausea (1,006) Asthma (972) Wheezing (951) Product use in unapproved indication (886) Cough (837)

What Other Drugs Cause Central nervous system lesion?

FINGOLIMOD (2,416) DIMETHYL (1,152) INTERFERON BETA-1A (978) NATALIZUMAB (627) DALFAMPRIDINE (561) GLATIRAMER (492) TERIFLUNOMIDE (315) ADALIMUMAB (229) OFATUMUMAB (185) RITUXIMAB (151)

Which AZITHROMYCIN Alternatives Have Lower Central nervous system lesion Risk?

AZITHROMYCIN vs AZITHROMYCIN ANHYDROUS AZITHROMYCIN vs AZITHROMYCIN OR METHOTREXATE AZITHROMYCIN vs AZOSEMIDE AZITHROMYCIN vs AZTREONAM AZITHROMYCIN vs AZTREONAM LYSINE

Related Pages

AZITHROMYCIN Full Profile All Central nervous system lesion Reports All Drugs Causing Central nervous system lesion AZITHROMYCIN Demographics